Across TCGA patient cohorts, RPL17P26 RNA expression is significantly associated with the protein abundance of many other proteins, with 11,678 significant associations in total. LSCC shows the largest number of these associations.

The most reproducible RPL17P26-associated proteins across cancer lineages are MYL6B, NOL11, and COLGALT1. Each is linked with RPL17P26 in more than 3 cancer types. Because this analysis shows association rather than direction, both RPL17P26-to-partner and partner-to-RPL17P26 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL17P26→partner) and Y-score (partner→RPL17P26) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner protein	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
COAD	MYL6B →	-0.323	-0.144	.002	.008	3	4
LSCC	NOL11 →	+0.288	+0.469	.001	<.001	3	4
BRCA	COLGALT1 →	+0.389	+0.790	<.001	<.001	3	4
BRCA	DDX21 →	+0.628	+0.860	<.001	<.001	3	4
BRCA	DDX52 →	+0.337	+0.702	<.001	<.001	3	4
BRCA	TPX2 →	+0.574	+0.580	.004	.005	3	4

Each partner links to its Q-omics profile. Showing the 6 strongest of 11,678 associations by consensus.

Exploration

RPL17P26 survival (RNA) · tumor vs normal (RNA) · all RPL17P26 data types